Cases 61 - 70 of 181
UCB, Inc. et al v. Annora Pharma Private Limited et al
as 1:2020cv00987
Defendant:
Aurobindo Pharma USA Inc., Lupin Ltd., Apotex Corp. and others
Plaintiff:
UCB Biopharma SRL and UCB, Inc.
Cause Of Action: 35 U.S.C. § 271
Cephalon, Inc. v. Aurobindo Pharma, Ltd. et al
as 1:2020cv00962
Defendant:
Aurobindo Pharma USA, Inc., Aurobindo Pharma, Ltd. and Eugia Pharma Specialities Ltd.
Plaintiff:
Cephalon, Inc.
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Aurobindo Pharma Limited et al
as 1:2020cv00949
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Limited
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al
as 1:2020cv00632
Plaintiff:
Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. and Cephalon, Inc.
Defendant:
Aurobindo Pharma, Ltd., Aurobindo Pharma USA, Inc. and Eugia Pharma Specialities Ltd.
Cause Of Action: 35 U.S.C. § 271
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC.
as 1:2020cv03102
Plaintiff:
JANSSEN RESEARCH AND DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV, MITSUBISHI TANABE PHARMA CORPORATION and others
Defendant:
AUROBINDO PHARMA USA, INC.
Cause Of Action: 15 U.S.C. § 1126
MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA INC.
as 3:2020cv03106
Plaintiff:
JANSSEN RESEARCH AND DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV, MITSUBISHI TANABE PHARMA CORPORATION and others
Defendant:
AUROBINDO PHARMA USA INC.
Cause Of Action: 15 U.S.C. § 1126
BAUSCH HEALTH US, LLC et al v. AUROBINDO PHARMA USA INC. et al
as 3:2020cv02738
Defendant:
AUROBINDO PHARMA USA INC. and AUROBINDO PHARMA LTD.
Plaintiff:
KAKEN PHARMACEUTICAL CO., LTD., BAUSCH HEALTH IRELAND LIMITED, BAUSCH HEALTH US, LLC and others
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. AUROBINDO PHARMA LIMITED et al
as 2:2020cv02606
Defendant:
AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALTIES LIMITED, AUROLIFE PHARMA LLC and others
Plaintiff:
CELGENE CORPORATION
Cause Of Action: 15 U.S.C. § 1126
MERCK SHARP & DOHME B.V. et al v. AUROBINDO PHARMA USA, INC. et al
as 3:2020cv02576
Defendant:
AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LIMITED
Plaintiff:
ORGANON USA INC. and MERCK SHARP & DOHME B.V.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
